Vogel, Annette B. https://orcid.org/0000-0002-9940-5379
Kanevsky, Isis
Che, Ye https://orcid.org/0000-0002-1278-4442
Swanson, Kena A. https://orcid.org/0000-0002-3389-8414
Muik, Alexander https://orcid.org/0000-0003-4561-2273
Vormehr, Mathias https://orcid.org/0000-0001-7788-3380
Kranz, Lena M. https://orcid.org/0000-0003-1943-3431
Walzer, Kerstin C.
Hein, Stephanie
Güler, Alptekin
Loschko, Jakob
Maddur, Mohan S.
Ota-Setlik, Ayuko
Tompkins, Kristin
Cole, Journey
Lui, Bonny G.
Ziegenhals, Thomas
Plaschke, Arianne
Eisel, David
Dany, Sarah C.
Fesser, Stephanie
Erbar, Stephanie
Bates, Ferdia https://orcid.org/0000-0001-8088-4835
Schneider, Diana
Jesionek, Bernadette
Sänger, Bianca
Wallisch, Ann-Kathrin
Feuchter, Yvonne
Junginger, Hanna
Krumm, Stefanie A.
Heinen, André P.
Adams-Quack, Petra
Schlereth, Julia
Schille, Stefan
Kröner, Christoph
de la Caridad Güimil Garcia, Ramón
Hiller, Thomas
Fischer, Leyla
Sellers, Rani S.
Choudhary, Shambhunath
Gonzalez, Olga
Vascotto, Fulvia
Gutman, Matthew R.
Fontenot, Jane A.
Hall-Ursone, Shannan
Brasky, Kathleen
Griffor, Matthew C.
Han, Seungil https://orcid.org/0000-0002-1070-3880
Su, Andreas A. H.
Lees, Joshua A.
Nedoma, Nicole L.
Mashalidis, Ellene H.
Sahasrabudhe, Parag V.
Tan, Charles Y.
Pavliakova, Danka
Singh, Guy
Fontes-Garfias, Camila https://orcid.org/0000-0002-1912-8413
Pride, Michael
Scully, Ingrid L.
Ciolino, Tara
Obregon, Jennifer
Gazi, Michal
Carrion, Ricardo Jr https://orcid.org/0000-0001-7046-7683
Alfson, Kendra J.
Kalina, Warren V.
Kaushal, Deepak https://orcid.org/0000-0003-3521-1257
Shi, Pei-Yong https://orcid.org/0000-0001-5553-1616
Klamp, Thorsten
Rosenbaum, Corinna
Kuhn, Andreas N.
Türeci, Özlem
Dormitzer, Philip R. https://orcid.org/0000-0003-0671-6360
Jansen, Kathrin U.
Sahin, Ugur
Article History
Received: 1 September 2020
Accepted: 20 January 2021
First Online: 1 February 2021
Competing interests
: The authors declare that U.S. and Ö.T. are management board members and employees at BioNTech SE (Mainz, Germany); K.C.W., B.G.L., D.S., B.J., T.H., T.K. and C.R. are employees at BioNTech SE; A.B.V., A.M., M.V., L.M.K., S. Hein, A.G., T.Z., F.B., A.P., D.E., S.C.D., S.F., S.E., F.B., B.S., A.K.-W., Y.F., H.J., S.A.K., S.S., A.P.H., P.A.-Q., J.S., A.A.H.S., C.K., R.d.l.C.G.G., L.F. and A.N.K. are employees at BioNTech RNA Pharmaceuticals GmbH (Mainz, Germany); A.B.V., A.M., K.C.W., A.G., S.F., A.N.K and U.S. are inventors on patents and patent applications related to RNA technology and COVID-19 vaccines; A.B.V., A.M., M.V., L.M.K., K.C.W., S. Hein, B.G.L., A.P., D.E., S.C.D., S.F., S.E., D.S., B.J., B.S., A.P.H., P.A.-Q., J.S., A.A.H.S., T.H., L.F., C.K., T.K., C.R., A.N.K., Ö.T. and U.S. have securities from BioNTech SE; I.K., Y.C., K.A.S. J.A.L. M.S.M., K.T., A,O.-S., J.A.F., M.C.G., S. Han, J.A.L., E.H.M., N.L.N., P.V.S., C.Y.T., D.P., W.V.K., J.O., R.S.S., S.C., T.C., I.L.S., M.W.P., G.S., and P.R.D., K.U.J. are employees of Pfizer and may hold stock options; C.F.-G. and P.-Y.S. received compensation from Pfizer to perform neutralization assays; M.R.G. received compensation from Pfizer to read and interpret radiographs and computed tomography scans. J.C., S.H.-U., K.B., R.C., Jr., K.J.A. O.G. and D.K., are employees of Southwest National Primate Research Center, which received compensation from Pfizer to conduct the animal challenge work; M.G. is an employee of Texas Biomedical Research Institute, which received compensation from Pfizer to conduct the RT–qPCR quantification of viral load. The authors declare no other relationships or activities that could appear to have influenced the submitted work.
Free to read: This content has been made available to all.